Monday, February 20, 2017

Study shows strong long-term survival rates for patients with GIST

Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.



from Top Health News – ScienceDaily http://ift.tt/2meDVx9
from Tumblr http://ift.tt/2lnbqhs
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)